Table 1 Laboratory data, genetic screening and bone marrow analysis
From: Splanchnic vein thrombosis following renal transplantation: a case report
Value | Reference range | |
|---|---|---|
WBC count, ×103/mm3 | 6.4 | |
Hgb level, g/L. | 13.2 | |
Haematocrit, % | 42.1 | |
Platelet count, ×103/mm3 | 630 | |
Peripheral blood smear | (%) | |
Neutrophils | 67 | |
Lymphocytes | 25 | |
Monocytes | 6 | |
Eosinophils | 1 | |
Basophils | 1 | |
Thrombophilia parameters | (%) | (%) |
Antithrombin III (AT III) | 115.5 | 75-125 |
Protein C (PC) | 98.4 | 70-140 |
Protein S (PS) | 87.2 | 60-130 |
Activated PC resistance (APCR) | 0.36 | 0.69-1.56 |
(sec.) | ||
Lupus anticoagulant (LA) | 45.1 | 31-34 |
Lupus anticoagulant confirmation | 36.5 | 30-38 |
Genetic screening | (pos./neg.) | Comment |
Factor V Leiden mutation | Positive | Heterozygot carrier |
BCR-ABL Mutation | Negative | |
prothrombin G20210A mutation | Negative | |
JAK2 V617F mutation | Positive | |
Bone marrow biopsy | YES/NO | |
Increased cellularity | Yes | (60%) |
Dyserythropoesis | No | |
Dysgranulopoesis | No | |
Megakaryocyte abnormality | Yes | Dysplastic changes |
Clustering of megakaryocytes | Yes | Paratrabecular localization |
Haemophagocytosis | No | |
Fibrosis | No |